TargetCancer Foundation
  • About
    • About TCF
    • Our Impact
    • Our Team
    • Partners & Collaborators
    • News & Updates
    • Frequently Asked Questions
    • Financials
  • Learn
    • Rare Cancer Resources
    • What is a Rare Cancer?
    • Initial Steps After a Rare Cancer Diagnosis
    • Biomarker Testing in Rare Cancers
    • Rare Cancer Treatments
    • Tissue-Agnostic Therapies in Rare Cancers
    • Clinical Trials
    • Video Library
    • Glossary
  • Research
    • Our Initiatives
    • TCF-001 TRACK
    • Our Funded Research
    • Scientific Meetings
    • Publications
  • Events
    • TCF Events
    • TargetCancer Foundation Gala
    • A Night to Strike Out Rare Cancer
    • Webinars
    • Scientific Meetings
    • Boston Marathon
    • Rare Cancer Day
  • Get Involved
    • Ways to Get Involved
    • Donate
    • Plan a Community Fundraiser
    • Join Team TCF
    • Speak Up to Save Rare Cancer Research
    • Golf Fights Cancer Golf Marathon
    • Volunteer
  • Blog
  • Contact
Donate
Closing the Book on Readers and Writers in NUT Carcinoma | Christopher French

Closing the Book on Readers and Writers in NUT Carcinoma | Christopher French

by | Mar 13, 2025

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLjVkdTVLUXdVRlVF At the 2024 Think Tank on Advancing Precision Medicine in Rare Cancers, Christopher A. French made a presentation titled "Closing the Book on Readers and Writers in NUT Carcinoma.
At the 2024 Think Tank on Advancing Precision Medicine in Rare Cancers, Christopher A. French made a presentation titled “Closing the Book on Readers and Writers in NUT Carcinoma.
The Power of Personal Experience: Patients and Caregivers as Drivers of Rare Cancer Research

The Power of Personal Experience: Patients and Caregivers as Drivers of Rare Cancer Research

by | Feb 20, 2025

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLkx5STl0WTZKa09r The Power of Personal Experience: Patients and Caregivers as Drivers of Rare Cancer Research was a panel discussion at the TargetCancer Foundation's Think Tank on Advancing Precision Medicine in Rare Cancers event in November 2024. It featured the perspectives and insights of advocacy organization leaders and caregivers Kristen Palma (President, TargetCancer Foundation), Michael Casaus (Co-Founder, cureMEC: The Myoepithelial Carcinoma Project), and Suzanne Vince (Vice President, Max Vincze Foundation).
The Power of Personal Experience: Patients and Caregivers as Drivers of Rare Cancer Research was a panel discussion at the TargetCancer Foundation’s Think Tank on Advancing Precision Medicine in Rare Cancers event in November 2024. It featured the perspectives...
The Precision Patient: Seeking Out Innovative, Science-Based Therapy for Patients with Rare Cancers

The Precision Patient: Seeking Out Innovative, Science-Based Therapy for Patients with Rare Cancers

by | Jan 15, 2025

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLk9GQVkzSDZzS2NJ Featuring Allen Chankowsky, Keynote Speaker<br />Recorded at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers<br />November 20, 2024 Boston, MA<br />www.targetcancer.org
Featuring Allen Chankowsky, Keynote Speaker Recorded at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers November 20, 2024 Boston, MA...
Dr. Razelle Kurzrock: N-of-1 Patient Centric Clinical Trials

Dr. Razelle Kurzrock: N-of-1 Patient Centric Clinical Trials

by | Jan 15, 2025

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLlRYOXZ6dTJwZ0w4 Featuring Razelle Kurzrock, MD<br />Recorded at the Think Tank on Advancing Precision Medicine in Rare Cancers<br />November 20, 2024 Boston, MA<br />www.targetcancer.org
Featuring Razelle Kurzrock, MD Recorded at the Think Tank on Advancing Precision Medicine in Rare Cancers November 20, 2024 Boston, MA...
Revolutionizing Rare Cancer Drug Development with Novel Tumour-Agnostic Classifiers & AI Innovations

Revolutionizing Rare Cancer Drug Development with Novel Tumour-Agnostic Classifiers & AI Innovations

by | Jan 15, 2025

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLi1yRThzbGxSb1Bv Featuring Vivek Subbiah, MD<br />Recorded at the Think Tank on Advancing Precision Medicine in Rare Cancers<br />November 20, 2024 Boston, MA<br />www.targetcancer.org
Featuring Vivek Subbiah, MD Recorded at the Think Tank on Advancing Precision Medicine in Rare Cancers November 20, 2024 Boston, MA...
« Older Entries
Next Entries »

Recent Posts

  • Putting Rare Cancers on the Map: Reflections from ASCO 2026
  • $1 Million and Counting: How Our 2026 Boston Marathon Team Made History
  • More Than a Diagnosis: Finding Wealth in the Rare Cancer Community
  • Immunotherapy: A Potential Step Forward for Treating Rare Cancers
  • Life Is About Relationships: What Cholangiocarcinoma Has Taught Us

Recent Comments

No comments to show.
Contact Us
(617) 765-4881
Join our Mailing List

Privacy(Required)
Donate
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Platinum Transparency 2025 Candid Charity Navigator Four-Star

TargetCancer Foundation
TargetCancer Foundation is a recognized 501(c)(3) charity, Tax ID 26-4510094.

  • About TCF
    • Our Impact
    • Our Team
    • Partners & Collaborators
    • News & Updates
    • Frequently Asked Questions
    • Financials
  • OnTarget Blog
  • Contact
  • Learn
    • What is a Rare Cancer?
    • Initial Steps After a Rare Cancer Diagnosis
    • Biomarker Testing in Rare Cancers
    • Clinical Trials
    • Video Library
    • Glossary
  • Research
    • TCF-001 TRACK
    • Our Funded Research
    • Scientific Meetings
    • Webinars
    • Publications
  • Events
    • TargetCancer Foundation Gala
    • Webinars
    • A Night to Strike Out Rare Cancer
    • Scientific Meetings
    • Boston Marathon
    • Rare Cancer Day
  • Get Involved
    • Donate
    • Plan a Community Fundraiser
    • Join Team TCF
    • Speak Up to Save Rare Cancer Research
    • Volunteer

All content and images copyright © 2026 TargetCancer Foundation. All rights reserved. | Privacy Policy